Literature DB >> 31823314

Translating CKD Research into Primary Care Practice: a Group-Randomized Study.

Cara B Litvin1, Paul J Nietert2, Ruth G Jenkins3, Andrea M Wessell3, Lynne S Nemeth4, Steven M Ornstein3.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is common in the primary care setting. Early interventions may prevent progression of renal disease and reduce risk for cardiovascular complications, yet quality gaps have been documented. Successful approaches to improve identification and management of CKD in primary care are needed.
OBJECTIVE: To assess whether implementation of a primary care improvement model results in improved identification and management of CKD
DESIGN: 18-month group-randomized study PARTICIPANTS: 21 primary care practices in 13 US states caring for 107,094 patients
INTERVENTIONS: To promote implementation of CKD improvement strategies, intervention practices received clinical quality measure (CQM) reports at least quarterly, hosted an on-site visit and 2 webinars, and sent clinician/staff representatives to a "best practice" meeting. Control practices received CQM reports at least quarterly. MAIN MEASURES: Changes in practice adherence to a set of 11 CKD CQMs KEY
RESULTS: We observed significantly greater improvements among intervention practices for annual screening for albuminuria in patients with diabetes or hypertension (absolute change 22% in the intervention group vs. - 2.6% in the control group, p < 0.0001) and annual monitoring for albuminuria in patients with CKD (absolute change 21% in the intervention group vs. - 2.0% in the control group, p < 0.0001). Avoidance of NSAIDs in patients with CKD declined in both intervention and control groups, with a significantly greater decline in the control practices (absolute change - 5.0% in the intervention group vs. - 10% in the control group, p < 0.0001). There were no other significant changes found for the other CQMs. Variable implementation of CKD improvement strategies was noted across the intervention practices.
CONCLUSIONS: Implementation of a primary care improvement model designed to improve CKD identification and management resulted in significantly improved care on 3 out of 11 CQMs. Incomplete adoption of improvement strategies may have limited further improvement. Improving CKD identification and management likely requires a longer and more intensive intervention.

Entities:  

Keywords:  chronic kidney disease; primary care; quality improvement

Mesh:

Year:  2019        PMID: 31823314      PMCID: PMC7210359          DOI: 10.1007/s11606-019-05353-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  46 in total

Review 1.  11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

2.  A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Authors:  Thomas J Hoerger; John S Wittenborn; Joel E Segel; Nilka R Burrows; Kumiko Imai; Paul Eggers; Meda E Pavkov; Regina Jordan; Susan M Hailpern; Anton C Schoolwerth; Desmond E Williams
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

3.  Recognition and management of CKD in primary care.

Authors:  Cara B Litvin; Paul J Nietert; Andrea M Wessell; Ruth G Jenkins; Steven M Ornstein
Journal:  Am J Kidney Dis       Date:  2011-01-22       Impact factor: 8.860

4.  Chronic kidney disease in the United States: a public policy imperative.

Authors:  Richard A Rettig; Keith Norris; Allen R Nissenson
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

5.  Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.

Authors:  Meredith C Foster; Andreea M Rawlings; Elizabeth Marrett; David Neff; Kerry Willis; Lesley A Inker; Josef Coresh; Elizabeth Selvin
Journal:  Am Heart J       Date:  2013-05-01       Impact factor: 4.749

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening.

Authors:  Paul J Nietert; Ruth G Jenkins; Lynne S Nemeth; Steven M Ornstein
Journal:  Contemp Clin Trials       Date:  2008-10-22       Impact factor: 2.226

Review 8.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Vlado Perkovic; Jorgen Hegbrant; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-05-31

Review 9.  Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

Authors:  T Ninomiya; V Perkovic; F Turnbull; B Neal; F Barzi; A Cass; C Baigent; J Chalmers; N Li; M Woodward; S MacMahon
Journal:  BMJ       Date:  2013-10-03

10.  Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial.

Authors:  Jennifer K Carroll; Gerald Pulver; L Miriam Dickinson; Wilson D Pace; Joseph A Vassalotti; Kim S Kimminau; Brian K Manning; Elizabeth W Staton; Chester H Fox
Journal:  JAMA Netw Open       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.